Boston Scientific Corporation (BSX): Price and Financial Metrics


Boston Scientific Corporation (BSX): $44.90

-0.11 (-0.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BSX POWR Grades


  • Growth is the dimension where BSX ranks best; there it ranks ahead of 99.38% of US stocks.
  • BSX's strongest trending metric is Growth; it's been moving up over the last 47 weeks.
  • BSX's current lowest rank is in the Momentum metric (where it is better than 42.16% of US stocks).

BSX Stock Summary

  • BSX has a higher market value than 95.73% of US stocks; more precisely, its current market capitalization is $62,948,525,568.
  • BSX's current price/earnings ratio is 119.67, which is higher than 93.36% of US stocks with positive earnings.
  • Over the past twelve months, BSX has reported earnings growth of 137.63%, putting it ahead of 84.69% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Boston Scientific Corp, a group of peers worth examining would be BDX, TEL, IFF, ALC, and A.
  • BSX's SEC filings can be seen here. And to visit Boston Scientific Corp's official web site, go to www.bostonscientific.com.

BSX Valuation Summary

  • BSX's price/sales ratio is 5.7; this is 50% higher than that of the median Healthcare stock.
  • BSX's price/sales ratio has moved up 2.7 over the prior 243 months.
  • Over the past 243 months, BSX's price/sales ratio has gone up 2.7.

Below are key valuation metrics over time for BSX.

Stock Date P/S P/B P/E EV/EBIT
BSX 2021-08-31 5.7 4 122.2 78.3
BSX 2021-08-30 5.7 4 121.4 77.8
BSX 2021-08-27 5.7 4 121.3 77.8
BSX 2021-08-26 5.7 4 120.9 77.5
BSX 2021-08-25 5.7 4 121.3 77.8
BSX 2021-08-24 5.7 4 121.4 77.8

BSX Growth Metrics

  • Its 4 year price growth rate is now at 64.56%.
  • Its 3 year revenue growth rate is now at 29.51%.
  • The 5 year revenue growth rate now stands at 46.02%.
Over the past 52 months, BSX's revenue has gone up $2,615,000,000.

The table below shows BSX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 11,197 2,243 526
2021-03-31 10,123 1,869 201
2020-12-31 9,913 1,508 -115
2020-09-30 10,109 1,527 3,685
2020-06-30 10,157 1,386 3,980
2020-03-31 10,785 1,409 4,287

BSX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BSX has a Quality Grade of C, ranking ahead of 69.32% of graded US stocks.
  • BSX's asset turnover comes in at 0.362 -- ranking 121st of 182 Medical Equipment stocks.
  • MMM, ABMD, and INGN are the stocks whose asset turnover ratios are most correlated with BSX.

The table below shows BSX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.362 0.669 0.051
2021-03-31 0.328 0.649 0.032
2020-12-31 0.324 0.650 0.015
2020-09-30 0.331 0.672 0.003
2020-06-30 0.344 0.682 0.022
2020-03-31 0.386 0.704 0.043

BSX Price Target

For more insight on analysts targets of BSX, see our BSX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $50.87 Average Broker Recommendation 1.41 (Moderate Buy)

BSX Stock Price Chart Interactive Chart >

Price chart for BSX

BSX Price/Volume Stats

Current price $44.90 52-week high $46.28
Prev. close $45.01 52-week low $32.99
Day low $44.64 Volume 5,313,510
Day high $45.12 Avg. volume 7,844,357
50-day MA $44.32 Dividend yield N/A
200-day MA $40.55 Market Cap 63.93B

Boston Scientific Corporation (BSX) Company Bio


Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. The company was founded in 1979 and is based in Marlborough, Massachusetts.


BSX Latest News Stream


Event/Time News Detail
Loading, please wait...

BSX Latest Social Stream


Loading social stream, please wait...

View Full BSX Social Stream

Latest BSX News From Around the Web

Below are the latest news stories about Boston Scientific Corp that investors may wish to consider to help them evaluate BSX as an investment opportunity.

Respiratory and Anesthesia Disposables Market 2021 Clinical Research with Top Leading Companies | Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Becton, Dickinson and Company (BD), Teleflex Incorporated, ResMed, Smiths Group plc.

The Respiratory and Anesthesia Disposables Market is present scenario evidently states that the pandemic will continue to determine various aspects of the healthcare industry in foreseeable future, as a result, the demand for disposables such as masks, filters, nasal cannulas,

OpenPR | September 11, 2021

TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today

T2 Biosystems has announced a breakthrough in Covid-19 variant testing.

Samuel O'Brient on InvestorPlace | September 10, 2021

Transradial Access Market Analysis and Forecast 2028 By Keyplayers Stryker, CARDINAL HEALTH, Angiodynamics Inc., BD, Terumo Corporation, Teleflex Incorporated, Smiths Group plc, MEDTRONIC, Boston Scientific Corporation, Edwards Lifesciences Corporation

Transradial access market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2,413.79 million by 2027 growing at a CAGR of 8.80% in the

OpenPR | September 10, 2021

Here's Why You Should Retain Boston Scientific (BSX) for Now

Investors are optimistic about Boston Scientific (BSX) given a strong second-quarter performance and strength in the Structural Heart business.

Yahoo | September 10, 2021

Cardiology Defibrillator Devices Market 2021-2027: Medtronic, Nihon Kohden, Boston Scientific Corporation, Cardiac Science Corporation, Heartsine Technologies

Global Cardiology Defibrillator Devices Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of

OpenPR | September 9, 2021

Read More 'BSX' Stories Here

BSX Price Returns

1-mo -0.55%
3-mo 4.37%
6-mo 17.63%
1-year 11.72%
3-year 20.47%
5-year 91.06%
YTD 24.90%
2020 -20.50%
2019 27.96%
2018 42.56%
2017 14.61%
2016 17.30%

Continue Researching BSX

Want to see what other sources are saying about Boston Scientific Corp's financials and stock price? Try the links below:

Boston Scientific Corp (BSX) Stock Price | Nasdaq
Boston Scientific Corp (BSX) Stock Quote, History and News - Yahoo Finance
Boston Scientific Corp (BSX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8537 seconds.